RxDoctor Payments Data

Steve Krikoriantz

Physician Assistant · Oroville, CANPI 1780786657

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $44,860 of the $68,377 with a category attached, or 65.6%. It is spread thinly across 44 manufacturers, the largest accounting for just 18.9%. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$68,377in general payments, 2019–2025

Across 1,338 payments — averaging $51.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$13K
  • Dermavant Sciences, Inc.$12K
  • E.r. Squibb & Sons, L.L.C.$7K
  • Sun Pharmaceutical Industries Inc.$5K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$4K
  • Arcutis Biotherapeutics, Inc.$4K
  • plus $24K from 38 others

What the payments were for

  • Consulting fees$13,70820%
  • Travel & lodging$9,35514%
  • Food & beverage$44,86066%
  • Education$4541%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$68,377 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab192$699,344
Cosentyx Sensoready (2 Pens)Secukinumab71$539,628
VtamaTapinarof191$423,945
OtezlaApremilast87$418,615
OpzeluraRuxolitinib Phosphate166$327,752
SiliqBrodalumab35$180,483
Dupixent SyringeDupilumab47$171,350
Enbrel MiniEtanercept22$157,072
Cosentyx Unoready PenSecukinumab13$134,074
SotyktuDeucravacitinib19$118,477
Enbrel SureclickEtanercept12$88,384
ZoryveRoflumilast49$40,430
Calcipotriene175$24,232
Fluorouracil243$22,146
TazoracTazarotene32$14,466

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Dermavant Sciences, Inc.Vtama$12,023$423,945191 claims
AmgenOtezla$2,432$418,61587 claims
Incyte CorporationOpzelura$2,174$327,752166 claims
Ortho Dermatologics, A Division Of Bausch Health US, LLCSiliq$3,648$180,48335 claims
E.r. Squibb & Sons, L.L.C.Sotyktu$7,051$118,47719 claims
Arcutis Biotherapeutics, Inc.Zoryve$3,557$40,43049 claims
PfizerEucrisa$1,233$13,41018 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$13$9012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Oroville

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →